SF Bay Area Indymedia indymedia
About Contact Subscribe Calendar Publish Print Donate

U.S. | Health, Housing, and Public Services

Chemotherapy Increases Cancer Cell Growth, Kills Healthy Cells
by Pharma Chemo Kills for Profit
Monday Oct 28th, 2013 12:02 PM
New research from Fred Hutchison Cancer Research Center in Seattle shows that chemotherapy damages healthy tissue around tumors and causes cancer cells to become resistant and using damaged DNA of healthy cells to create cancer "super" cells that grow faster than before treatment. The pharmaceutical industry monopolizes the treatment field with toxic chemotherapy while using their FDA puppets to suppress lower cost yet more effective alternative treatments currently only available outside the U.S. and at great cost to patients.



Chemotherapy actually increases cancer growth, cancer cells becoming resistant to treatment: Study

Friday, October 18, 2013 by: Jonathan Benson, staff writer

(NaturalNews) The cancer treatment scam that is chemotherapy has once again been shown in the scientific literature to be a major cause of, rather than a cure for, cancer. According to a new study recently published in the peer-reviewed journal Nature, chemotherapy not only promotes the growth and spread of cancer cells by damaging the healthy tissue that surrounds tumors, but it also causes cancer cells to develop full-on resistance to the popular treatment, morphing them into "super" cancer cells.

Researchers from the Fred Hutchison Cancer Research Center in Seattle, Washington, learned this after observing the effects of chemotherapy on healthy cell tissue. What they found is something that we here at NaturalNews have been saying for years, but that the medical system as a whole is only just now waking up to -- chemotherapy, which is a recognized poison, damages the DNA of healthy, non-cancerous cells, causing them to produce molecules that in turn produce more cancer cells.

It does not take a rocket scientist to make this deduction, of course, as simple common sense dictates that blasting healthy cells along with unhealthy cells is going to cause damage to all of the cells. But this is apparently big news up in the Northwest, where scientists are apparently baffled as to how this can be. And we are not talking about minor damage here -- according to the figures, major damage to healthy cells occurs as a result of routine chemotherapy treatments.

"[T]he researchers found that chemotherapy can cause fibroblasts (cell DNA) to increase production of a molecule called WNT16B by 30-fold in tissues surrounding a tumor," explains the group Cancer Research U.K. in a recent report on the study. "This then helps cancer cells to grow, invade neighboring cells and resist chemotherapy," it adds.


'Super' cancer cells caused by chemotherapy more deadly than ever
As if this is not bad enough, the same team found that another major side effect of chemotherapy is cancer cells grow more virulent than they were before the treatment. Like "superbugs" and "superweeds," which we now know developed resistance in response to conventional drug therapies and chemical sprayings, respectively, these "super" cancer cells no longer respond even to the most aggressive forms of chemotherapy, which means cancer itself is becoming more deadly.

"These results delineate a mechanism by which genotoxic therapies given in a cyclical manner can enhance subsequent treatment resistance through cell nonautonomous effects that are contributed by the tumor microenvironment," explains the study abstract.

You can read the fully study abstract here:
http://www.nature.com/nm/journal/v18/n9/full/nm.2890.html

Not surprisingly, at least one doctor heavily vested in the cancer industry has already come out to call not for an end to chemotherapy but rather for the development of new treatments that might alter the body's natural resistance mechanisms to better accommodate the toxic effects of chemotherapy. This is how the conventional medical system operates, of course -- simply add new drugs into the mix to cover up the side effects of other drugs, and lather, rinse, repeat.

"Most cancer patients in this country die of chemotherapy," explains Dr. Allen Levin, M.D., from the University of California, San Francisco, in his book, The Healing of Cancer. "Chemotherapy does not eliminate breast, colon, or lung cancers. This fact has been documented for over a decade, yet doctors still use chemotherapy for these tumors."

If you or a loved one suffers from cancer, there are alternatives to chemotherapy and radiation. The Gerson Therapy; Dr. Stanislaw Burzynski's antineoplastons; cannabis oil containing high levels of healing cannabinoids; and freshly-juiced marijuana leaves are all viable cancer treatment protocols that have healed many people. You can learn more about each of these methods at the following links:

http://gerson.org
http://www.burzynskiclinic.com
http://www.sfweekly.com
http://www.naturalnews.com

Sources for this article include:

http://www.cancerresearchuk.org

http://www.nature.com

http://tv.greenmedinfo.com

http://www.cancertutor.com

http://gerson.org


Learn more:

http://www.naturalnews.com/042563_chemotherapy_cancer_growth_treatment_resistance.html#ixzz2j2n1mY96



Cancer chemotherapy resistance: Hutchinson Center team discovers new mechanism



Noncancerous fibroblasts when exposed to chemotherapy sustain DNA damage that drives the production of an array of factors that stimulate solid tumor cancer growth


Aug. 6, 2012



By Kristen Woodward





Dr. Peter Nelson of the Human Biology Division

Photo by Dean Forbes


Developing resistance to chemotherapy is a nearly universal, ultimately lethal consequence for cancer patients with solid tumors – such as those of the breast, prostate, lung and colon – that have metastasized throughout the body. A team of scientists led by the Hutchinson Center has discovered a key factor that drives this drug resistance – information that ultimately may be used to improve the effectiveness of therapy and buy precious time for patients with advanced cancer.

"Cancer cells inside the body live in a very complex environment or neighborhood. Where the tumor cell resides and who its neighbors are influence its response and resistance to therapy," said senior author Dr. Peter Nelson, of the Hutchinson Center’s Human Biology Division. The findings were published online Aug. 5 in advance of print publication in Nature Medicine.

Collaborators at the Center

Co-authors included first author Dr. Yu Sun, staff scientist in the Nelson Lab; Drs. Peggy Porter of Human Biology; Ilsa Coleman of the Nelson Lab; and Dr. Tia Higano of the Clinical Research Division and University of Washington. Porter, Dr. Nicole Urban of the Public Health Sciences Division, and Dr. Beverly Torok-Storb of Clinical Research provided tissue samples for the study.

Nelson and colleagues found that a type of normal, noncancerous cell that lives in cancer’s neighborhood – the fibroblast – when exposed to chemotherapy sustains DNA damage that drives the production of a broad spectrum of growth factors that stimulate cancer growth. Under normal circumstances, fibroblasts help maintain the structural integrity of connective tissue, and they play a critical role in wound healing and collagen production.

Specifically, the researchers found that DNA-damaging cancer treatment coaxes fibroblasts to crank out a protein called WNT16B within the tumor neighborhood, or microenvironment, and that high levels of this protein enable cancer cells to grow, invade surrounding tissue and resist chemotherapy.



'Completely unexpected' increased WNT production

The researchers observed up to 30-fold increases in WNT production – a finding that was "completely unexpected," Nelson said. The WNT family of genes and proteins plays an important role in normal development and also in the development of some cancers but, until now, was not known to play a significant role in treatment resistance.

This discovery suggests that finding a way to block this treatment response in the tumor microenvironment may improve the effectiveness of therapy.

"Cancer therapies are increasingly evolving to be very specific, targeting key molecular engines that drive the cancer rather than more generic vulnerabilities, such as damaging DNA. Our findings indicate that the tumor microenvironment also can influence the success or failure of these more precise therapies." In other words, the same cancer cell, when exposed to different "neighborhoods," may have very different responses to treatment.

The major clinical reason that chemotherapy ultimately fails in the face of advanced cancer, Nelson said, is because the doses necessary to thoroughly wipe out the cancer would also be lethal to the patient.

"In the laboratory we can 'cure' most any cancer simply by giving very high doses of toxic therapies to cancer cells in a petri dish. However, in people, these high doses would not only kill the cancer cells but also normal cells and the host," he said.

Therefore, treatments for common solid tumors are given in smaller doses and in cycles, or intervals, to allow the normal cells to recover. This approach may not eradicate all of the tumor cells, and those that survive can evolve to become resistant to subsequent rounds of anti-cancer therapy.

For the study the team of researchers – which also involved investigators at the University of Washington, Oregon Health and Science University, the Buck Institute for Research on Aging, the Lawrence Berkeley National Laboratory – examined cancer cells from prostate, breast and ovarian cancer patients who had been treated with chemotherapy.



Research investment paying off

"This study is an example of collaborative, translational research that capitalizes on years of federally funded investments into the development of tissue banks and clinical trials in which we were able to track long-term patient outcomes. Investing in this type of infrastructure is critical but may take many years to see payoff," said Nelson, who serves as principal investigator of the Pacific Northwest Prostate Cancer SPORE, a federally funded, multi-institution research consortium led by the Hutchinson Center.

The National Institutes of Health, the National Cancer Institute, the Department of Defense and the Prostate Cancer Foundation funded the research.

http://www.fhcrc.org/en/news/center-news/2012/08/peter-nelson-lab-chemotherapy-resistance-mechanism.html



What The Cancer Industrial Complex Does Not Want You To Know About Chemotherapy and Radiation




By: Dave Mihalovic, Prevent Disease, Guest

They tell us chemotherapy saves lives, boosts long-term survival rates and does not damage healthy cells. All these statements by the cancer industry are false. Poison kills indiscriminately– always has and always will. While damaging healthy cells, chemotherapy also triggers them to secrete a protein that sustains tumour growth and resistance to further treatment. That’s right…chemotherapy will actually boost cancer growth and cancer treatment is the leading cause of secondary cancers.

Vaccines, pharmaceuticals, diagnostics and therapies, dentistry, psychiatry and practically all medical research is an industry and driver of corporate profits. The cancer industry is particularly ironic because the products that cause many cancers are made by divisions of the same multi-national corporations whose subsidiaries make the scanners and equipment that is used to diagnose cancers, the drugs used in chemotherapy and those given to prevent the cancer returning.

In what reality do we live in when cut, poison and burn are the only ways acceptable to treat cancer?

The cancer industry destroys or marginalizes safe and effective cures while promoting their patented, expensive, and toxic remedies that do more harm than good.

No chemotherapy drug has ever actually cured or resolved the underlying causes of cancer. Even what mainstream medicine considers “successful” chemotherapy treatments are only managing symptoms, usually at the cost of interfering with other precious physiological functions in patients that will cause side effects down the road. There is no such thing as a drug without a side effect.

Chemotherapy and Radiation May Kill Cancer, But They Also Kill You

Chemotherapy has a number of post-treatment adverse effects. Most chemotherapeutic agents do enter the brain and they can directly and indirectly produce a number of acute and delayed changes to the central nervous system. These effects can last for years, then dissipate, or, when they occur in young children, can ripple into adulthood.

The long-term survival rates of chemotherapy patients are grossly exaggerated because most of these patients end up dying of diseases unrelated to the original cancer itself, but instead related to the treatment.

Chemotherapy drugs (especially alkylating agents) are known to cause other cancers including leukemia many of these drugs fall into this class. Alkylating agents directly damage DNA of all cells. These agents are not phase-specific; in other words, they work in all phases of the cell cycle. Because these drugs damage DNA, they can cause long-term damage to the bone marrow and consequently affect long-term immunity. With these drugs, the risk for a second cancer develops slowly over time but their diagnosis is inevitable. Studies have shown that the risk begins to rise about two years after treatment, is highest about five to 10 years after treatment. It’s the reason most chemotherapy patients die 10-15 years after treatment.

Radiation therapy can also increase the risk of developing cancer in most people. The types of cancers linked to radiation therapy are vast, but primarily consist of leukemia and sarcomas. These cases typically develop a few years after radiation exposure with the peak of risk being about five to nine years after exposure. Again, most patients that pursue radiation therapy develop secondary cancers related to treatment and not as a consequence of the original cancer. Radiation-induced cancershave exploded in the past two decades ever since radiation has proliferated as a treatment, usually secondary to chemotherapy.

Some other cancer risks are tied to radiation therapy, as well. Solid tumors can develop at or near the site of the radiation exposure even 10 or more years after the radiation therapy. These risks seem to be greatest in certain areas of the body, such as the breast and the thyroid. In some of these cases, your age at the time of radiation treatment plays a role. For example, younger breast cancer patients are more likely to develop a second cancer from radiation therapy than older breast cancer patients.

Doctors Speak Out About The Cancer Industry

Dr. Robert Atkins, MD, of Atkins Diet fame once announced there are several cures for cancer, but there’s no money in them. They’re natural, effective, and inexpensive, no expensive drugs are involved but they require quite a lot of self-discipline from patients. It costs millions to fund research and clinical trials needed to produce a new cancer drug that can be patented and sold. Often these drugs create more illness. It has been said that the key to success in the health business is to pull off the trick of making people patients for life. Consider how many people who registered a couple of abnormal blood pressure readings have been kept on medication until the medication killed them, when a quick fix course of drugs supported by major changes of diet and lifestyle would have returned their physical condition to an unmedicated healthy state.

According to Dr. John Diamond, M.D., “A study of over 10,000 patients shows clearly that chemo’s supposedly strong track record with Hodgkin’s disease (lymphoma) is actually a lie. Patients who underwent chemo were 14 times more likely to develop leukemia and 6 times more likely to develop cancers of the bones, joints, and soft tissues than those patients who did not undergo chemotherapy.”

Dr. Glenn Warner, who died in 2000, was one of the most highly qualified cancer specialists in the United States. He used alternative treatments on his cancer patients with great success. On the treatment of cancer in this country he said: “We have a multi-billion dollar industry that is killing people, right and left, just for financial gain. Their idea of research is to see whether two doses of this poison is better than three doses of that poison.”

Dr. Alan C. Nixon, past president of the American Chemical Society writes, “As a chemist trained to interpret data, it is incomprehensible to me that physicians can ignore the clear evidence that chemotherapy does much, much more harm than good.” And according to Dr. Charles Mathe, French cancer specialist, “…if I contracted cancer, I would never go to a standard cancer treatment centre. Only cancer victims who live far from such centres have a chance.”

Dr. Allen Levin stated: “Most cancer patients in this country die of chemotherapy. Chemotherapy does not eliminate breast, colon, or lung cancers. This fact has been documented for over a decade, yet doctors still use chemotherapy for these tumors.” In his book, The Topic of Cancer: When the Killing Has to Stop, Dick Richards cites a number of autopsy studies which have shown that cancer patients actually died from conventional treatments before the tumor had a chance to kill them.

How Chemotherapy Actually Boosts Cancer Growth

Researchers tested the effects of a type of chemotherapy on tissue collected from men with prostate cancer, and found “evidence of DNA damage” in healthy cells after treatment, the scientists wrote in Nature Medicine.

Chemotherapy works by inhibiting reproduction of fast-dividing cells such as those found in tumours.

The scientists found that healthy cells damaged by chemotherapy secreted more of a protein called WNT16B which boosts cancer cell survival.

“The increase in WNT16B was completely unexpected,” study co-author Peter Nelson of the Fred Hutchinson Cancer Research Center in Seattle told AFP.

The protein was taken up by tumour cells neighbouring the damaged cells.

“WNT16B, when secreted, would interact with nearby tumour cells and cause them to grow, invade, and importantly, resist subsequent therapy,” said Nelson.

In cancer treatment, tumours often respond well initially, followed by rapid regrowth and then resistance to further chemotherapy.

Rates of tumour cell reproduction have been shown to accelerate between treatments.

“Our results indicate that damage responses in benign cells… may directly contribute to enhanced tumour growth kinetics,” wrote the team.

The researchers said they confirmed their findings with breast and ovarian cancer tumours.

Patients with incurable cancers are promised much greater access to the latest drugs which could offer them extra months or years of life, however many doctors have been urged to be more cautious in offering cancer treatment to terminally-ill patients as chemotherapy can often do more harm than good, advice supported by Nelson’s study.

90% of Patients Who Receive Chemotherapy Suffer Fatal Effects

The National Confidential Enquiry into Patient Outcome and Death (NCEPOD) found that more than four in ten patients who received chemotherapy towards the end of life suffered potentially fatal effects from the drugs, and treatment was “inappropriate” in nearly a fifth of cases.

Globally, almost 90% of patients who are administered chemotherapy die within 15 years of treatment either from secondary cancers, or a compromised immunity as a direct consequence of the treatment. Chemotherapy and radiation combined are the leading cause of secondary cancer worldwide.

There has been a 68% increase in the use of chemotherapy drugs since 2003 and despite the massive increase in the incidence of cancer since then; the risk factors (according to the cancer industry) for primary and secondary cancers are still related to tobacco, alcohol, occupational exposures and genetic determinants. Cancer treatment or diagnostics is never mentioned as a cause of any primary or secondary cancers.

Cancer is a leading cause of disease worldwide and if recent trends in major cancers are seen globally in the future, the burden of cancer will increase to 22 million new cases each year by 2030. This represents an increase of 75% compared with 2008

More than half of all cancer patients suffer significant treatment-related toxicity. Treatment can also result in life-threatening infections or patients may simply die of their cancer.

When asked about how to improve a patient’s response and outcome, Nelson replied “alternatively, it may be possible to use smaller, less toxic doses of therapy.”

But small doses of poison are still poison.

The bottom line is that chemotherapy destroys virtually all cells and systems before getting to the actual cancer. This means your central nervous system, organ systems and your immune system (to name just a few) are all compromised even years after the treatment has subsided. Forget about cancer killing you because chemotherapy will do a much better job in the long term.

Chemotherapy causes healthy brain cells to die off long after treatment has ended and may be one of the underlying biological causes of the cognitive side effects — or “chemo brain” — that many cancer patients experience.

Conventional cancer treatment is a massive and expensive fraud–a non-treatment that sickens and kills more people than it ever “cures.” It can never cure anything because it poisons the body which only causes more disease in the future.

The question [of whether or not chemotherapy really extends life, ed.] can probably no longer be answered. In clinical studies the manufacturers always compare their new drugs with older cellular poisons. There are no control groups that are given no treatment at all.

In order to be allowed onto the market, it suffices to achieve a “statistically significant” advantage in one small group of hand- picked test subjects vs. those treated with some already approved cellular poison.

About the Author

Dave Mihalovic is a Naturopathic Doctor who specializes in vaccine research, cancer prevention and a natural approach to treatment


- See more at: http://www.themindunleashed.org/2013/10/what-cancer-industrial-complex-does-not.html#sthash.gHWUQ0US.dpuf










word to the wise;




The suppression of this information is criminal



Please read Death by Medicine, by Gary Null PhD, Carolyn Dean MD ND, Martin Feldman MD, Debora Rasio MD, Dorothy Smith PhD.



This is not about bad mouthing anyone. There are better things to do with time. It is about exposing the truth. There are many fine, caring physicians. When a person experiences a trauma from an accident, a severe laceration, by all means, of course you require medical treatment. Let’s not mix compassion with profit. Medicine started out based on compassion.



First, do no harm, right? We should prevent what we treat? Where are we now?



Big Pharma sends their beautiful reps to doctors’ offices to convince them of how they should be getting more people on this drug or that one, despite side effects. It’s for profit and it is deplorable and sad.



Be aware of your rights; don’t be badgered or scared into doing what “everyone else is doing” only to wind up a statistic.

Do your research now while you’re healthy

Don’t wait until you are in a crisis mode

Stay healthy

Grow your own vegetables

Drink purified water

Take nutrients

Question authority

And by all means Wake Up World...!

http://www.bibliotecapleyades.net/salud/salud_defeatcancer112.htm